Investigation of Binding Features: Effects on the Interaction between CYP2A6 and Inhibitors

被引:26
作者
Ai, Chunzhi [1 ,2 ]
Li, Yan [3 ]
Wang, Yonghua [4 ]
Li, Wei [1 ,2 ]
Dong, Peipei [1 ,2 ]
Ge, Guangbo [1 ,2 ]
Yang, Ling [1 ]
机构
[1] Chinese Acad Sci, Dalian Inst Chem Phys, Lab Pharmaceut Resource Discovery, Dalian 116023, Peoples R China
[2] Chinese Acad Sci, Grad Sch, Beijing 100049, Peoples R China
[3] Dalian Univ Technol, Sch Chem Engn, Dalian 116012, Peoples R China
[4] NW A&F Univ, Coll Life Sci, Xian 712100, Peoples R China
基金
中国国家自然科学基金;
关键词
CYP2A6-ligand interaction; docking; molecular electrostatic potential; molecular lipophilic potential; orbital energies; INCREMENTAL CONSTRUCTION ALGORITHM; NICOTINE METABOLISM; SMOKING-BEHAVIOR; CYTOCHROME-P-450; 2A6; CIGARETTE-SMOKING; IN-SILICO; DOCKING; DEPENDENCE; DENSITY; FIELDS;
D O I
10.1002/jcc.21455
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A computational investigation has been carried out on CYP2A6 and its naphthalene inhibitors to explore the crucial molecular features contributing to binding specificity. The molecular bioactive orientations were obtained by docking (FlexX) these compounds into the active site of the enzyme. And the density functional theory method was further used to optimize the molecular structures with the subsequent analysis of molecular lipophilic potential (MLP) and molecular electrostatic potential (MEP). The minimal MLPs, minimal MEPs, and the band gap energies (the energy difference between the highest occupied molecular orbital and lowest unoccupied molecular orbital) showed high correlations with the inhibition activities (pIC(50)s), illustrating their significant roles in driving the inhibitor to adopt an appropriate bioactive conformation oriented in the active site of CYP2A6 enzyme. The differences in MLPs, MEPs, and the orbital energies have been identified as key features in determining the binding specificity of this series of compounds to CYP2A6 and the consequent inhibitory effects. In addition, the combinational use of the docking, MLP and MEP analysis is also demonstrated as a good attempt to gain an insight into the interaction between CYP2A6 and its inhibitors. (c) 2010 Wiley Periodicals, Inc. J Comput Chem 31: 1822-1831, 2010
引用
收藏
页码:1822 / 1831
页数:10
相关论文
共 52 条
[31]   The genetics of nicotine dependence: Relationship to pancreatic cancer [J].
MacLeod, Stewart L. ;
Chowdhury, Parimal .
WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (46) :7433-7439
[32]   Impact of CYP2A6 genotype on pretreatment smoking behaviour and nicotine levels from and usage of nicotine replacement therapy [J].
Malaiyandi, V ;
Lerman, C ;
Benowitz, NL ;
Jepson, C ;
Patterson, F ;
Tyndale, RF .
MOLECULAR PSYCHIATRY, 2006, 11 (04) :400-409
[33]   Limitation of cigarette consumption by CYP2A6*4, *7 and *9 polymorphisms [J].
Minematsu, N ;
Nakamura, H ;
Furuuchi, M ;
Nakajima, T ;
Takahashi, S ;
Tateno, H ;
Ishizaka, A .
EUROPEAN RESPIRATORY JOURNAL, 2006, 27 (02) :289-292
[34]   Electrostatic interactions in the hairpin ribozyme account for the majority of the rate acceleration without chemical participation by nucleobases [J].
Nam, Kwangho ;
Gao, Jiali ;
York, Darrin M. .
RNA, 2008, 14 (08) :1501-1507
[35]   Genetically decreased CYP2A6 and the risk of tobacco dependence:: a prospective study of novice smokers [J].
O'Loughlin, J ;
Paradis, G ;
Kim, W ;
DiFranza, J ;
Meshefedjian, G ;
McMillan-Davey, E ;
Wong, S ;
Hanley, J ;
Tyndale, RF .
TOBACCO CONTROL, 2004, 13 (04) :422-428
[36]   Nicotine metabolism defect reduces smoking [J].
Pianezza, ML ;
Sellers, EM ;
Tyndale, RF .
NATURE, 1998, 393 (6687) :750-750
[37]   A comparative molecular field analysis of cytochrome P450 2A5 and 2A6 inhibitors [J].
Poso, A ;
Gynther, J ;
Juvonen, R .
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2001, 15 (03) :195-202
[39]   Identification of inhibitors of the nicotine metabolising CYP2A6 enzyme -: an in silico approach [J].
Rahnasto, M. ;
Wittekindt, C. ;
Juvonen, R. O. ;
Turpeinen, M. ;
Petsalo, A. ;
Pelkonen, O. ;
Poso, A. ;
Stahl, G. ;
Holtje, H-D ;
Raunio, H. .
PHARMACOGENOMICS JOURNAL, 2008, 8 (05) :328-338
[40]   Quantitative structure-activity relationship analysis of inhibitors of the nicotine metabolizing CYP2A6 enzyme [J].
Rahnasto, M ;
Raunio, H ;
Poso, A ;
Wittekindt, C ;
Juvonen, RO .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (02) :440-449